Transcriptional regulators of motor columnar specification

运动柱状规范的转录调节因子

基本信息

  • 批准号:
    9900077
  • 负责人:
  • 金额:
    $ 51.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

Our overarching research goal is to comprehensively understand the gene regulatory network that directs the development of various motor columns (MCs) in the spinal cord and how each MC contributes to the neural circuitry for locomotion. This proposal is designed to study a MC named PreGanglionic MC (PGC, aka CT for Column of Terni in chick), which is found only in thoracic levels of the spinal cord and contains visceral motor neurons (vMNs) that control the activity of the sympathetic nervous system (SymNS). In sympathetic ganglia, the axons of PGC motor neurons (MNs) form synapse with sympathetic neurons, which then regulate the activity of smooth muscle fibers, cardiac muscles, and glands. Given that vMNs in the PGC control the SymNS, which targets various internal organs, it is tempting to speculate that PGC is not a homogenous cell population and instead consists of multiple subtypes. However, despite recent advances in our generation mechanisms of spinal MCs, little is known about either that specify PGC identity. This study the cellular composition of PGC understanding of the MNs or the molecular will interrogate these two major issues in the field. Our strong preliminary findings led to our hypothesis: PGC MNs have multiple subtypes and Jun is a vital transcription factor in the gene regulatory network that directs fate-specification, differentiation, diversification, cell body migration, and axonal projection of PGC MNs.” To dissect this hypothesis, we will employ an ensemble of cellular, biochemical, genetic and unbiased genome-wide approaches.
我们的首要研究目标是全面了解基因调控网络,指导人类的健康

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Soo-Kyung Lee其他文献

Soo-Kyung Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Soo-Kyung Lee', 18)}}的其他基金

Transcriptional regulators of motor columnar specification
运动柱状规范的转录调节因子
  • 批准号:
    9754418
  • 财政年份:
    2019
  • 资助金额:
    $ 51.65万
  • 项目类别:
Transcriptional regulators of motor columnar specification
运动柱状规范的转录调节因子
  • 批准号:
    10625972
  • 财政年份:
    2019
  • 资助金额:
    $ 51.65万
  • 项目类别:
Transcriptional regulators of motor columnar specification
运动柱状规范的转录调节因子
  • 批准号:
    10399970
  • 财政年份:
    2019
  • 资助金额:
    $ 51.65万
  • 项目类别:
Transcriptional Regulators of Motor Columnar Specification
运动柱状规范的转录调节器
  • 批准号:
    10167282
  • 财政年份:
    2019
  • 资助金额:
    $ 51.65万
  • 项目类别:
FoxG1-directed Gene Network in Forebrain Development and FoxG1 Syndrome
FoxG1 引导的前脑发育和 FoxG1 综合征中的基因网络
  • 批准号:
    10246537
  • 财政年份:
    2017
  • 资助金额:
    $ 51.65万
  • 项目类别:
FoxG1-directed Gene network in forebrain development and FoxG1 syndrome
FoxG1主导的前脑发育和FoxG1综合征中的基因网络
  • 批准号:
    9401898
  • 财政年份:
    2017
  • 资助金额:
    $ 51.65万
  • 项目类别:
FoxG1-directed Gene network in forebrain development and FoxG1 syndrome
FoxG1主导的前脑发育和FoxG1综合征中的基因网络
  • 批准号:
    9486007
  • 财政年份:
    2017
  • 资助金额:
    $ 51.65万
  • 项目类别:
FoxG1-directed Gene network in forebrain development and FoxG1 syndrome
FoxG1主导的前脑发育和FoxG1综合征中的基因网络
  • 批准号:
    10167246
  • 财政年份:
    2017
  • 资助金额:
    $ 51.65万
  • 项目类别:
LIM-HD/bHLH Combinatorial Code in Motoneurons
运动神经元中的 LIM-HD/bHLH 组合代码
  • 批准号:
    8531360
  • 财政年份:
    2006
  • 资助金额:
    $ 51.65万
  • 项目类别:
LIM-HD/bHLH Combinatorial Code in Motoneurons
运动神经元中的 LIM-HD/bHLH 组合代码
  • 批准号:
    7576920
  • 财政年份:
    2006
  • 资助金额:
    $ 51.65万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 51.65万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 51.65万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 51.65万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.65万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 51.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 51.65万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 51.65万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 51.65万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 51.65万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 51.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了